Article: Texas Biotechnology Reports Third Quarter Financial Results; Updates Shareholders on Key Operations.

Article: Texas Biotechnology Acquires ICOS Corporation's ...
Business Wire;  April 23, 2003 ;     700+ words ... ... adults. About Texas Biotechnology Corporation Texas Biotechnology Corporation, a biopharmaceutical company focused on the ... learn more about Texas Biotechnology please visit our ... product-driven company that has expertise ...

Article: Texas Biotechnology to Reacquire Full Development ...
PR Newswire;  January 30, 2003 ;     700+ words ... ... Sitaxsentan is Texas Biotechnology's lead product ... Under the ICOS-Texas Biotechnology L.P. agreement ... between the two companies. Texas Biotechnology recently reached ... trial, and the Company intends to launch ...

Article: Pharmacopeia and Texas Biotechnology Announce ...
PR Newswire;  November 20, 1997 ;     700+ words ... ... thrombocytopenia. Texas Biotechnology is also conducting ... asthma. Texas Biotechnology Corporation ... technology, the Company generates ... pharmaceutical companies for evaluation ... biotechnology companies and academic ... that the Company files from ... various reports ...

Article: TEXAS BIOTECHNOLOGY REGAINING RIGHTS TO PAH DRUG ...
BIOWORLD Today;  February 3, 2003 ;     700+ words ... ... You might say Texas Biotechnology Corp. is taking ... Houston-based company plans to reacquire ... developed by ICOS-Texas Biotechnology LP, a partnership ... quite well." Texas Biotechnology's first FDA ... We are not a company that's new ...

Article: Texas Biotechnology Implements Restructuring Plan; ...
PR Newswire;  January 7, 2003 ;     700+ words ... ... likely to accelerate Texas Biotechnology's transition into ... profitable pharmaceutical company." Dr. Given added ... early 2003. About Texas Biotechnology Texas Biotechnology, a biopharmaceutical company focused on the discovery ...

Article: Texas Biotechnology and SmithKline Beecham Form ...
PR Newswire;  August 6, 1997 ;     700+ words ... ... development of NOVASTAN, the Company has completed Phase ... antagonist for asthma. The Company expects to begin Phase ... second half of 1997. Texas Biotechnology's expertise in computer ... information, visit the Company's Internet web site ... leading healthcare companies -- discovers, ...

Article: Texas Biotechnology Reports Fourth Quarter Results
PR Newswire;  February 18, 1998 ;     700+ words ... ... study will allow the Company to proceed with clinical ... regimes in future trials. Texas Biotechnology Corporation is a biopharmaceutical company engaged in the development ... induced thrombocytopenia. Texas Biotechnology is also conducting Phase ...